CAS: 1587727-31-8
![2-[(1S)-1-[(2S,5R)-5-[4-Chloro-5-fluoro-2-(trifluoromethyl)phenyl]tetrahydro-2-furanyl]ethyl]-3,4-…](https://static.cymitquimica.com/products/3D/thumb/MNC72731.jpg)
2-[(1S)-1-[(2S,5R)-5-[4-Chloro-5-fluoro-2-(trifluoromethyl)phenyl]tetrahydro-2-furanyl]ethyl]-3,4-dihydro-7-(4-methyl-1H-imidazol-1- yl)-2H-pyrido[1,2-a]pyrazine-1,6-dione
CAS:1587727-31-8
2-[(1S)-1-[(2S,5R)-5-[4-Chloro-5-fluoro-2-(trifluoromethyl)phenyl]tetrahydro-2-furanyl]ethyl]-3,4-dihydro-7-(4-methyl-1H-imidazol-1- yl)-2H-pyrido[1,2-a]pyrazine-1,6-dione is a research tool with the molecular formula C17H20ClF3N3O. It is an activator …
Formula:
C25H23ClF4N4O3
Purity:
Min. 95%
Molecular weight:
538.9 g/mol
Ref: 3D-MNC72731
| 1mg | 1,276.00 € | ||
| 2mg | 1,855.00 € | ||
| 5mg | 2,493.00 € | ||
| 10mg | 4,347.00 € | ||
| 500µg | 863.00 € |
Estimated delivery in United States, on Wednesday 18 Dec 2024
PF-06648671
CAS:1587727-31-8
PF-06648671 is a γ-secretase modulator for the treatment of neurodegenerative and/or neurological disorders.
Formula:
C25H23ClF4N4O3
Purity:
98%
Color and Shape:
Solid
Molecular weight:
538.92
Ref: TM-T24621
| 25mg | 2,523.00 € | ||
| 50mg | 3,346.00 € | ||
| 100mg | 4,580.00 € |
Estimated delivery in United States, on Wednesday 5 Feb 2025
